Login

Verona Pharma plc 3 SEC Filings

Filed On Filing
07 Mar 2024 Form 3: Fisher Andrew, General Counsel

No securities owned

02 Feb 2024 Form 3: Austwick Michael, Director

No securities owned

05 Sep 2023 Form 3: Ackermann Christina, Director

No securities owned

17 Aug 2022 Form 3: Access Industries Holdings Llc, 10% owner and 3 others

Holds 51,111,648 shares of Ordinary Shares

16 Mar 2022 Form 3: Brady James Aloysius, Director

No securities owned

03 Mar 2021 Form 3: Deschamps Lisa, Director

No securities owned

05 Jan 2021 Form 3: Orbimed Advisors Llc, Director and 1 other

Holds 40,225,392 shares of Ordinary Shares

05 Jan 2021 Form 3: Gupta Rishi, Director

Holds 40,225,392 shares of Ordinary Shares

04 Jan 2021 Form 3: Sonsini Peter W., 10% owner

Holds 9,757,393 shares of Ordinary Shares

04 Jan 2021 Form 3: Sandell Scott D, 10% owner

Holds 9,757,393 shares of Ordinary Shares

04 Jan 2021 Form 3: Makower Joshua, 10% owner

Holds 9,757,393 shares of Ordinary Shares

04 Jan 2021 Form 3: Makhzoumi Mohamad, 10% owner

Holds 9,757,393 shares of Ordinary Shares

04 Jan 2021 Form 3: Florence Anthony A. Jr., 10% owner

Holds 9,757,393 shares of Ordinary Shares

04 Jan 2021 Form 3: Baskett Forest, 10% owner

Holds 9,757,393 shares of Ordinary Shares

04 Jan 2021 Form 3: Rickard Kathleen A., Chief Medical Officer

Holds 3,067,152 shares of Ordinary Shares

04 Jan 2021 Form 3: Poll Claire, General Counsel

Holds 2,762,639 shares of Ordinary Shares

04 Jan 2021 Form 3: Ebsworth David R, Director

Holds 707,739 shares of Ordinary Shares

04 Jan 2021 Form 3: Edwards Martin, Director

Holds 136,776 shares of Ordinary Shares

04 Jan 2021 Form 3: Sinha Vikas, Director

Holds 94,680 shares of Ordinary Shares

04 Jan 2021 Form 3: Ullman Anders, Director

Holds 357,712 shares of Ordinary Shares

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support